Literature DB >> 12824884

New aspects of IFN-alpha/beta signalling in immunity, oncogenesis and bone metabolism.

Akinori Takaoka1, Tadatsugu Taniguchi.   

Abstract

Although interferons (IFNs) were originally identified as humoral factors that confer an antiviral state upon cells, they have been demonstrated to be multifunctional in a variety of biological systems. The IFN-alpha/beta system modulates not only the cellular immune response to viral and bacterial infections, but also the oncogenic process and bone metabolism. Further studies have revealed additional unique facets of the IFN-alpha/beta system. A weak signal by constitutively produced IFN-alpha/beta is critical not only for the regulation of cellular amplification of IFN-alpha/beta production upon viral infection or the enhancement of signalling by other cytokines, but also for the regulation of adaptive immune responses, such as the enhancement of CD8()+ T cell activation. Furthermore, IFN-beta signalling is critical for the regulation of the bone-resorbing osteoclasts. In this review, we focus on the newly discovered roles of the IFN-alpha/beta system in host defense and bone remodeling, particularly on the functions of the weak IFN-alpha/beta signalling in the context of what we refer to as the "revving-up" model.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12824884     DOI: 10.1111/j.1349-7006.2003.tb01455.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  17 in total

Review 1.  Interferon-zeta/limitin: novel type I interferon that displays a narrow range of biological activity.

Authors:  Kenji Oritani; Yoshiaki Tomiyama
Journal:  Int J Hematol       Date:  2004-11       Impact factor: 2.490

2.  Suppression of STAT-1 expression by human papillomaviruses is necessary for differentiation-dependent genome amplification and plasmid maintenance.

Authors:  Shiyuan Hong; Kavi P Mehta; Laimonis A Laimins
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

3.  Protective role of interferon regulatory factor 3-mediated signaling against prion infection.

Authors:  Daisuke Ishibashi; Ryuichiro Atarashi; Takayuki Fuse; Takehiro Nakagaki; Naohiro Yamaguchi; Katsuya Satoh; Kenya Honda; Noriyuki Nishida
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

4.  Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon.

Authors:  Christophe Préhaud; Françoise Mégret; Mireille Lafage; Monique Lafon
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  Temporal and spatial resolution of type I and III interferon responses in vivo.

Authors:  Julia Elisabeth Pulverer; Ulfert Rand; Stefan Lienenklaus; Daniela Kugel; Natalia Zietara; Georg Kochs; Ronald Naumann; Siegfried Weiss; Peter Staeheli; Hansjörg Hauser; Mario Köster
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

6.  Posttranscriptional control of type I interferon genes by KSRP in the innate immune response against viral infection.

Authors:  Wei-Jye Lin; Xiaojia Zheng; Chen-Chung Lin; Jun Tsao; Xiaolin Zhu; James J Cody; Jennifer M Coleman; Roberto Gherzi; Ming Luo; Tim M Townes; Jacqueline N Parker; Ching-Yi Chen
Journal:  Mol Cell Biol       Date:  2011-06-20       Impact factor: 4.272

7.  Prevention of allograft tolerance by bacterial infection with Listeria monocytogenes.

Authors:  Tongmin Wang; Luqiu Chen; Emily Ahmed; Lianli Ma; Dengping Yin; Ping Zhou; Jikun Shen; Honglin Xu; Chyung-Ru Wang; Maria-Luisa Alegre; Anita S Chong
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

8.  Type I interferons in the treatment of pancreatic cancer: mechanisms of action and role of related receptors.

Authors:  Giovanni Vitale; Casper H J van Eijck; Peter M van Koetsveld Ing; Joris I Erdmann; Ernst Jan M Speel; Katy van der Wansem Ing; Diana M Mooij; Annamaria Colao; Gaetano Lombardi; Ed Croze; Steven W J Lamberts; Leo J Hofland
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

Review 9.  From bats to pangolins: new insights into species differences in the structure and function of the immune system.

Authors:  Patrick J Haley
Journal:  Innate Immun       Date:  2022-05-04       Impact factor: 2.951

10.  Pharmacogenomics of interferon-beta therapy in multiple sclerosis: baseline IFN signature determines pharmacological differences between patients.

Authors:  Lisa G M van Baarsen; Saskia Vosslamber; Marianne Tijssen; Josefien M C Baggen; Laura F van der Voort; Joep Killestein; Tineke C T M van der Pouw Kraan; Chris H Polman; Cornelis L Verweij
Journal:  PLoS One       Date:  2008-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.